Capricor Therapeutics, Inc. (CAPR)
7.565
+0.04
(+0.46%)
USD |
NASDAQ |
Nov 20, 15:35
Capricor Therapeutics 30-Day Average Daily Volume : 3.939M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 3.939M |
| November 18, 2026 | 3.755M |
| November 17, 2026 | 3.571M |
| November 16, 2026 | 3.519M |
| November 13, 2026 | 3.614M |
| November 12, 2026 | 3.580M |
| November 11, 2026 | 3.550M |
| November 10, 2026 | 3.900M |
| November 09, 2026 | 3.838M |
| November 06, 2026 | 3.749M |
| November 05, 2026 | 3.657M |
| November 04, 2026 | 3.580M |
| November 03, 2026 | 3.471M |
| November 02, 2026 | 3.405M |
| October 30, 2026 | 3.318M |
| October 29, 2026 | 3.314M |
| October 28, 2026 | 3.335M |
| October 27, 2026 | 3.315M |
| October 26, 2026 | 3.271M |
| October 23, 2026 | 3.316M |
| October 22, 2026 | 3.337M |
| October 21, 2026 | 3.342M |
| October 20, 2026 | 3.320M |
| October 19, 2026 | 3.342M |
| October 16, 2026 | 3.364M |
| Date | Value |
|---|---|
| October 15, 2026 | 3.434M |
| October 14, 2026 | 3.495M |
| October 13, 2026 | 3.621M |
| October 12, 2026 | 3.683M |
| October 09, 2026 | 3.808M |
| October 08, 2026 | 4.152M |
| October 07, 2026 | 4.470M |
| October 06, 2026 | 4.961M |
| October 05, 2026 | 5.526M |
| October 02, 2026 | 5.579M |
| October 01, 2026 | 5.762M |
| September 30, 2026 | 5.918M |
| September 29, 2026 | 5.517M |
| September 28, 2026 | 6.068M |
| September 25, 2026 | 8.210M |
| September 24, 2026 | 8.704M |
| September 23, 2026 | 8.716M |
| September 22, 2026 | 8.722M |
| September 21, 2026 | 8.742M |
| September 18, 2026 | 8.781M |
| September 17, 2026 | 8.780M |
| September 16, 2026 | 8.771M |
| September 15, 2026 | 8.832M |
| September 14, 2026 | 8.932M |
| September 11, 2026 | 9.078M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Regeneron Pharmaceuticals, Inc. | 910037.9 |
| SELLAS Life Sciences Group, Inc. | 13.02M |
| ARS Pharmaceuticals, Inc. | 2.199M |
| Sionna Therapeutics, Inc. | 867748.9 |